✦ LIBER ✦

Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?

✍ Scribed by Alfredo Alberti

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ribavirin dosage in patients with HCV ge

✍ A. MANGIA; O. DALGARD; N. MINERVA; H. VERBAAN; D. BACCA; H. RING-LARSEN; M. COPE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Individualized treatment with combinatio

✍ Alessandra Mangia; Franco Bandiera; Giuseppe Montalto; Leonardo Mottola; Valeria 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 687 KB

Peg-interferon alfa-2B 1.5μG/KG plus rib

📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

751 The safety and efficacy of viramidin

✍ Y. Benhamou; P. Pockros; M. Rodrieuez-Torres; S. Gordon; M. Shiffinan; Y. Lurie; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 117 KB

[10] THE SAFETY AND EFFICACY OF TARIBAVI

✍ P. Marcellin; Y. Lurie; M. Rodrigues-Torres; R. Chasen; Y. Xu; B. Murphy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 117 KB

A 3-ARM randomized study evaluating the

✍ Alessandra Mangia; Giovanni Ricci; Nicola Minerva; Marcello Persico; Vito Carret 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 100 KB